Caesarean scar pregnancy: comparative efficacy and safety of treatment by uterine artery chemoembolization and systemic methotrexate injection |
| |
Authors: | Wu Xia Zhang Xuebin Zhu Jie Di Wen |
| |
Institution: | Department of Obstetrics & Gynecology, Renji Hospital, Shanghai Jiaotong University, Shanghai, China. |
| |
Abstract: | ObjectivesThe aim of this study was to investigate the efficacy and safety of uterine artery embolization (UAE) combined with intra-arterial methotrexate (MTX) infusion for the treatment of caesarean scar pregnancy (CSP), compared with systemic MTX injection combined with uterine curettage.Study designA retrospective cohort study. An analysis of CSP patients was performed using records from the Department of Obstetrics and Gynecology in Renji Hospital for the period between January 1, 2000 and December 30, 2010. Twenty-two patients received UAE combined with intra-arterial MTX infusion and in this group 16 patients received uterine curettage after UAE, whereas 25 patients received intramuscular MTX injection and subsequent uterine curettage. The clinical information on these patients and clinical outcomes were reviewed.ResultsAll patients in the UAE group were treated successfully and 2 patients in the non-UAE group had to undergo hysterectomy or uterine repair. No patients in the UAE group had recurrent vaginal bleeding of more than 100 ml/day after treatment, while 8 patients in the non-UAE group did, and this difference was significant. The blood loss during uterine curettage in the UAE group was much less than in non-UAE group. The serum β-hCG level in the UAE group recovered more quickly than in the non-UAE group, and hospital stay was significantly shorter in the UAE group.ConclusionsUAE combined with intraarterial MTX infusion turned out to be an effective and safe treatment for CSP. |
| |
Keywords: | Caesarean scar pregnancy Uterine artery embolization Methotrexate Uterine curettage |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|